FY4/23
IR PRESENTATION
June 2023
Results Overview
© 2023 AIN HOLDINGS INC. All Rights Reserved. | 1 |
Consolidated P/L
Net sales increased 13.4% YoY and 0.2% against the plan due to new store openings and contribution of existing stores, despite the impact of the COVID-19. Ordinary profit increased 6.4% YoY and declined 5.4% against the plan due to increase of sales.
（¥ million）
FY4/22 | FY4/23 |
results | revised plan |
FY4/23 results
YoY | YoY | Vs plan |
change | change(%) | (%) |
Net sales | 316,247 | 358,000 | 358,742 | ＋42,495 | ＋13.4 | ＋0.2 |
Gross profit | 49,971 | 54,870 | 53,698 | ＋3,727 | ＋7.5 | (2.1) |
% of net sales | 15.8 | 15.3 | 15.0 | |||
SG&A expenses | 34,832 | 37,690 | 37,694 | ＋2,862 | ＋8.2 | ＋0.0 |
% of net sales | 11.0 | 10.5 | 10.5 | |||
Operating profit | 15,139 | 17,180 | 16,004 | ＋865 | ＋5.7 | (6.8) |
% of net sales | 4.8 | 4.8 | 4.5 | |||
Ordinary profit | 16,041 | 18,030 | 17,064 | ＋1,023 | ＋6.4 | (5.4) |
% of net sales | 5.1 | 5.0 | 4.8 | |||
Profit attributable to | 7,092 | 9,000 | 9,234 | ＋2,142 | ＋30.2 | ＋2.6 |
owners of parent | ||||||
% of net sales | 2.2 | 2.5 | 2.6 | |||
Earnings per | 201.47 | 256.20 | 262.87 | ＋61.40 | ＋30.5 | ＋2.6 |
share(¥) | ||||||
Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved. | 2 |
Dispensing Pharmacy Business (Consolidated)
Net sales increased 13.6% YoY and 0.0% against the plan due to new store openings including M&A and contribution of stores opened previous year. Segment profit declined 3.8% YoY and 5.4% against the plan.
（¥ million）
FY4/22 | FY4/23 |
results | revised plan |
FY4/23 results
YoY | YoY | Vs plan |
change | change(%) | (%) |
Net sales | 283,111 | 321,560 | 321,577 | ＋38,466 | ＋13.6 | ＋0.0 |
Gross profit | 38,194 | 41,350 | 39,779 | ＋1,585 | ＋4.1 | (3.8) |
% of net sales | 13.5 | 12.9 | 12.4 | |||
SG&A expenses | 13,875 | 16,620 | 16,559 | ＋2,684 | ＋19.3 | (0.4) |
% of net sales | 4.9 | 5.2 | 5.1 | |||
Operating profit | 24,319 | 24,730 | 23,220 | (1,099) | (4.5) | (6.1) |
% of net sales | 8.6 | 7.7 | 7.2 | |||
Segment profit | 25,082 | 25,520 | 24,135 | (947) | (3.8) | (5.4) |
% of net sales | 8.9 | 7.9 | 7.5 | |||
Number of | 1,099 | 1,210 | 1,209 | ＋110 | ＋10.0 | (0.1) |
pharmacies | ||||||
Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved. | 3 |
Cosmetic and Drug Store Business (Consolidated)
Net sales increased 24.9% YoY and 3.1% against the plan due to the recovery of existing stores, contribution of stores opened in previous year, and success of cost optimization despite the impact of the COVID-19. Segment profit was 38% against the plan, ¥2,978 million above the plan.
（¥ million）
FY4/22 | FY4/23 |
results | revised plan |
FY4/23 results
YoY | YoY | Vs plan |
Change | change(%) | (%) |
Net sales | 20,558 | 24,920 | 25,685 | ＋5,127 | ＋24.9 | ＋3.1 |
Gross profit | 7,030 | 9,410 | 9,694 | ＋2,664 | ＋37.9 | ＋3.0 |
% of net sales | 34.2 | 37.8 | 37.7 | |||
SG&A expenses | 8,858 | 8,570 | 8,521 | (337) | (3.8) | (0.6) |
% of net sales | 43.1 | 34.4 | 33.2 | |||
Operating profit | (1,827) | 840 | 1,172 | ＋2,999 | - | ＋39.5 |
% of net sales | - | 3.4 | 4.6 | |||
Segment profit | (1,764) | 880 | 1,214 | ＋2,978 | - | ＋38.0 |
% of net sales | - | 3.5 | 4.7 | |||
Number of | 78 | 78 | 78 | 0 | 0.0 | 0.0 |
stores | ||||||
Figures in the table are rounded down
© 2023 AIN HOLDINGS INC. All Rights Reserved. | 4 |